CFTR and cystic fibrosis: This fact is also supported by data from the other pilot studies showing higher PAP concentrations in CFSPID or patients with CFTR mutations leading to pancreatic sufficiency and low PAP concentrations in some patients with CFTR mutations leading to pancreatic insufficiency and a severe CF phenotype (e.g., [18]).